We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.
Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.
A serious shortage protocol (SSP) has been issued across the UK for Utrogestan® 100mg capsules today (19 May 2023).
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
37,700 women have purchased hormone replacement therapy (HRT) prescription prepayment certificates (PPC) following the launch, saving over £1.13 million.
From 1 April 2023, women in England will be able to access cheaper hormone replacement therapy (HRT) to help with menopause symptoms.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
The equality assessment presents the impacts of the introduction of the hormone replacement therapy prescription prepayment certificate (HRT PPC).
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.